Antibody-Drug Conjugates Attract Hefty Funding To ADC Therapeutics

 
• By John Davis
  
Chris Martin of ADC Therapeutics
Chris Martin, CEO of ADC Therapeutics • Source: ADC Therapeutics
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business